Poly(lactic-co-glycolic
acid) (PLGA) has been used for long-acting injectable drug delivery
systems for more than 30 years. The factors affecting the properties
of PLGA formulations are still not clearly understood. The drug release
kinetics of PLGA microparticles are influenced by many parameters
associated with the formulation composition, manufacturing process,
and post-treatments. Since the drug release kinetics have not been
explainable using the measurable properties, formulating PLGA microparticles
with desired drug release kinetics has been extremely difficult. Of
the various properties, the glass transition temperature, T
g, of PLGA formulations is able to explain various
aspects of drug release kinetics. This allows examination of parameters
that affect the T
g of PLGA formulations,
and thus, affecting the drug release kinetics. The impacts of the
terminal sterilization on the T
g and drug
release kinetics were also examined. The analysis of drug release
kinetics in relation to the T
g of PLGA
formulations provides a basis for further understanding of the factors
controlling drug release.